Genmab Stock Nasdaq Copenhagen
Stocks
DK0010272202
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,555.75 DKK | +27.83% |
|
+4.14% | +14.24% |
| Market Cap | 97.86B 15.19B 13.09B 12.05B 11.3B 21.24B 1,436B 21.45B 142B 55.65B 703B 57.01B 55.8B 2,433B | P/E Ratio 2026 * |
21.1x | P/E Ratio 2027 * | 14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 117B 18.22B 15.7B 14.45B 13.56B 25.46B 1,722B 25.72B 171B 66.73B 843B 68.36B 66.91B 2,917B | EV / Sales 2026 * |
4.24x | EV / Sales 2027 * | 3.4x |
| Free-Float |
95.41% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Genmab
| 1 day | -0.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/06/2010 | |
Anthony Pagano
DFI | Director of Finance/CFO | 48 | 01/03/2020 |
Rayne Waller
CTO | Chief Tech/Sci/R&D Officer | - | 16/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 01/11/2003 | |
| Director/Board Member | 58 | 01/01/2015 | |
| Director/Board Member | 75 | 01/01/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +29.29% | +4.14% | - | - | 15.19B | |
| -0.26% | +0.16% | +57.15% | +108.11% | 54.92B | |
| -0.34% | +3.51% | +45.55% | +40.16% | 44.31B | |
| +0.29% | +6.20% | -14.80% | -19.65% | 22.96B | |
| -0.40% | +3.49% | -1.29% | +387.06% | 21.12B | |
| -2.91% | +0.27% | +13.28% | -36.73% | 16.31B | |
| -0.24% | +2.44% | +27.43% | +177.49% | 13.32B | |
| +1.48% | +9.81% | +19.29% | - | 12.48B | |
| +0.32% | +2.81% | +96.37% | +213.49% | 11.21B | |
| +3.95% | +6.95% | +69.08% | +95.58% | 11.52B | |
| Average | +0.14% | +3.64% | +34.68% | +120.69% | 23.13B | |
| Weighted average by Cap. | -0.10% | +3.37% | +35.98% | +105.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 27.64B 4.29B 3.7B 3.4B 3.19B 6B 406B 6.06B 40.24B 15.72B 199B 16.1B 15.76B 687B | 32.41B 5.03B 4.34B 3.99B 3.74B 7.03B 476B 7.1B 47.19B 18.43B 233B 18.88B 18.48B 806B |
| Net income | 4.71B 732M 631M 580M 544M 1.02B 69.14B 1.03B 6.86B 2.68B 33.86B 2.75B 2.69B 117B | 7.02B 1.09B 939M 864M 811M 1.52B 103B 1.54B 10.22B 3.99B 50.43B 4.09B 4B 175B |
| Net Debt | 19.49B 3.03B 2.61B 2.4B 2.25B 4.23B 286B 4.27B 28.37B 11.08B 140B 11.35B 11.11B 484B | 12.47B 1.94B 1.67B 1.54B 1.44B 2.71B 183B 2.73B 18.15B 7.09B 89.59B 7.26B 7.11B 310B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
